Protocol summary

Study aim
Comparison of the effects of ketofol (Ketamine-Propofol mixture) with propofol on Transient agitation in children undergoing Adenotonsillectomy
Design
Clinical trial with control group, with parallel groups, double-blind, randomized, phase 3 on 64 patients. A random number table will be used for randomization.
Settings and conduct
This study is performed in Razi Hospital of Birjand, South Khorasan Province. 64 patients were randomly divided into two groups of adenotonsillectomy receiving propofol and ketofol. Then the agitation of patients in both groups is evaluated by the nurse at 15, 30 minutes in the recovery room and 2, 4 and 6 hours after surgery in the ward. Postoperative complications in patients, including: the presence or absence of nausea, vomiting, as well as the Modified objective pain score will be evaluated.
Participants/Inclusion and exclusion criteria
Candidates for tonsillectomy (adenotonsillectomy) who referred to Razi Hospital in Birjand in 1400. Inclusion criteria include: patients with ASA class one and two, aged 3 to 9 years, without any kinds of addiction and requirement to prescribe any narcotic drugs in recovery phase as well as any known previous propofol allergy reactions. exclusion criteria are defined as having mental and behavioral disorders, a specific rare disease, Cerebral trauma ,intracranial mass or bleeding and any congenital heart diseases.
Intervention groups
Intervention group 1, Patients receiving propofol made by Fresenius Kabi Company, Germany as a general intravenous anesthetic at a dose of 2 mg /kg daily before surgery. Intervention group 2, patients who receive ketofol (40 mg Ketamine made by Rotex Medica, Germany + 160 mg propofol 1%) as an intravenous anesthetic before surgery.
Main outcome variables
Agitation

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20190618043934N12
Registration date: 2021-07-11, 1400/04/20
Registration timing: retrospective

Last update: 2021-07-11, 1400/04/20
Update count: 0
Registration date
2021-07-11, 1400/04/20
Registrant information
Name
Zabihullah Mohaghegh
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 56 3232 3232
Email address
oabstudent@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2021-04-04, 1400/01/15
Expected recruitment end date
2021-07-06, 1400/04/15
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of the effects of ketofol (Ketamine-Propofol mixture) with propofol on Transient agitation in children undergoing Adenotonsillectomy
Public title
Effects of propofol and ketofol on transient agitation induced by adenotonsillectomy
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Patients with ASA class one and two Age 3 to 9 years Without any addiction Without any requirements to prescribe any Narcotic drugs in recovery phase Without any known previous propofol allergy reactions
Exclusion criteria:
Having mental and behavioral disorders Having a specific illness Cerebral trauma and bleeding or intracerebral mass Having congenital heart disease
Age
From 3 years old to 9 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Outcome assessor
Sample size
Target sample size: 32
Randomization (investigator's opinion)
Randomized
Randomization description
Participants in the study will be randomly divided into two groups after intervention with two drugs called ketofol (A) or propofol (B) using the block randomization process. Firstly, various quadruple blocks are created using a sealed envelope (AABB, BBAA, ABAB, BABA, ABBA, and BABA). One of these blocks is selected randomly and according to the order mentioned in the selected block, patients will be divided into one of two groups , namely A or B. Then randomization would be performed for other patients in the similar way.
Blinding (investigator's opinion)
Double blinded
Blinding description
Outcome evaluator=the nurse who was not informed of the type of medication received by the children, performed the necessary evaluation 15 and 30 minutes after the surgery in the recovery room as well as 2,4 and 6 hours post surgery evaluation which were done in the ward. Then, the evaluation data will be submitted to the specific checklist designed for this purpose. The children participating in the study, are not informed of the anesthetic agents that were given to them. Because they are not conscious while going under anesthesia and their lack of information about these kinds of anesthetic agents. The analyst= the analyst does not have any information about the placement of people in the study and conducts analysis on data based on the codes defined by the study leader
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee of Birjand University of Medical Sciences
Street address
Vice Chancellor for Research and Technology, Birjand University of Medical Sciences, Ghaffari Blvd, Birjand Town
City
Birjand
Province
South Khorasan
Postal code
9717811674
Approval date
2021-03-01, 1399/12/11
Ethics committee reference number
IR.BUMS.REC.1399.526

Health conditions studied

1

Description of health condition studied
Tonsillitis
ICD-10 code
J03
ICD-10 code description
Acute tonsillitis

Primary outcomes

1

Description
Agitation
Timepoint
15, 30 minutes after being in the recovery room and 2, 4 and 6 hours after surgery in the ward
Method of measurement
Using the Modified objective pain score criterion (MOPS)

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group 1: The first group in the interventional study are patients who received propofol (made by Fresnius Kabi company in Germany) as a general intravenous anesthetic with the prescribed dose of 2 mg per kg for induction anesthesia as well as 0.5 mg/kg dosage of atracurium ampoule as a skeletal muscle relaxant before the surgery.
Category
Treatment - Drugs

2

Description
Intervention group 2: The second group in the interventional study are patients who are given ketofol in the ratio of 1 : 4 (40 mg ketamine made by Rotex Medica company in Germany + 160 mg propofol 1%) as a preoperative intravenous anesthetic agent for induction anesthesia as well as 0.5 mg/kg dosage of atracurium ampoule as a skeletal muscle relaxant before the surgery.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Razi Hospital_Birjand
Full name of responsible person
Dr. Elahe Yamini
Street address
Razi Hospital, Ghafari Blvd, Birjand Town
City
Birjand
Province
South Khorasan
Postal code
9717934888
Phone
+98 56 3232 3232
Email
oabstudent@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Birjand University of Medical Sciences
Full name of responsible person
Dr. Tooba Kazemi
Street address
Vice Chancellor for Research and Technology, Birjand University of Medical Sciences, Ghaffari Blvd, Birjand Town
City
Birjand
Province
South Khorasan
Postal code
9717811674
Phone
+98 56 3238 1200
Email
research@bums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Birjand University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Birjand University of Medical Sciences
Full name of responsible person
Zabihullah Mohaghegh
Position
Student
Latest degree
Bachelor
Other areas of specialty/work
General Practitioner
Street address
No.56, Jorjani Ave, Ghahhari Blvd, Birjand Town
City
Birjand
Province
South Khorasan
Postal code
9717934888
Phone
+98 56 3232 3232
Email
zabihullahmohaghegh@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Birjand University of Medical Sciences
Full name of responsible person
Dr. Malihe Zangoee
Position
Member of the Faculty
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Department of Anesthesiology, School of Medicine, Birjand University of medical sciences, Ghahhari Blvd, Birjand Town
City
Birjand
Province
South Khorasan
Postal code
9717811674
Phone
+98 56 3232 3232
Email
mzangoue@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Birjand University of Medical Sciences
Full name of responsible person
Zabihullah Mohaghegh
Position
Student
Latest degree
Bachelor
Other areas of specialty/work
General Practitioner
Street address
No.56, Jorjani Ave, Ghaffari Blvd, Birjand Town
City
Birjand
Province
South Khorasan
Postal code
9717934888
Phone
+98 56 3232 3232
Email
zabihullahmohaghegh@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...